Manuela Callari

Experts / Manuela Callari

Science and Medical Writer Sydney

Manuela Callari, PhD, is an award-winning freelance science and medical journalist. She has a PhD in medical science, a bachelor’s and a master’s degree in material science, and a post-graduate degree in science communication.

Obesity drugs: Who will lose weight and for how long?

Which factors predict better outcomes with GLP-1 RAs and their successors...

Diabetes and metabolism, Diet and nutrition

Clinical Articles

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

By Manuela Callari

Clinical Articles

Diabetes and metabolism, Diet and nutrition

Obesity drugs: Who will lose weight and for how long?

Which factors predict better outcomes with GLP-1 RAs and their successors...

By Manuela Callari

Clinical Articles

Diet and nutrition

Manuela Callari

Science and Medical Writer Sydney

More from this expert

Obesity drugs: Who will lose weight and for how long?

Which factors predict better outcomes with GLP-1 RAs and their successors...

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Obesity drugs: Who will lose weight and for how long?

Which factors predict better outcomes with GLP-1 RAs and their successors...

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

POTS – What You Need to Know

Tuesday 17th February, 7pm - 9pm AEDT

Speaker

Prof Dennis Lau

Cardiac Electrophysiologist; The Royal Adelaide Hospital; Clinical Professor, The University of Adelaide

Hear the latest evidence-based management options for POTS - a common, yet poorly recognised and misunderstood autonomic dysfunction condition in our community. Join Prof Dennis Lau for an update on POTS, who is at risk, presenting symptoms and how it can be diagnosed in the primary care setting.

Manuela Callari

Science and Medical Writer Sydney

More from this expert

Obesity drugs: Who will lose weight and for how long?

Which factors predict better outcomes with GLP-1 RAs and their successors...

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Obesity drugs – What’s around the corner

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Obesity drugs: Who will lose weight and for how long?

Which factors predict better outcomes with GLP-1 RAs and their successors...

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

POTS – What You Need to Know

Tuesday 17th February, 7pm - 9pm AEDT

Speaker

Prof Dennis Lau

Cardiac Electrophysiologist; The Royal Adelaide Hospital; Clinical Professor, The University of Adelaide

Hear the latest evidence-based management options for POTS - a common, yet poorly recognised and misunderstood autonomic dysfunction condition in our community. Join Prof Dennis Lau for an update on POTS, who is at risk, presenting symptoms and how it can be diagnosed in the primary care setting.